Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · IEX Real-Time Price · USD
3.710
-0.030 (-0.80%)
Jul 26, 2024, 4:30 PM EDT - Market closed
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $82.56 million as of July 26, 2024.
Market Cap
82.56M
Enterprise Value
-22.24M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.71
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $82.56M, a decrease of -76.80%. That is a compound annual growth rate of -98.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 83.20M | -76.62% |
| Mar 28, 2024 | 355.83M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectar Biosciences | 83.71M |
| Hyperfine | 83.53M |
| Instil Bio | 83.19M |
| BioAtla | 82.28M |
| Genenta Science | 81.98M |
| Leap Therapeutics | 80.74M |
| Ikena Oncology | 80.59M |
| PetMed Express | 79.54M |